- Home
- DVN vs BNTX Comparison
DVN vs BNTX Comparison
Compare DVN & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DVN | BNTX |
|---|---|---|
| Founded | 1971 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | DVN | BNTX |
|---|---|---|
| Price | $36.09 | $93.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 11 |
| Target Price | $43.47 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 7.8M | 1.3M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.24 | N/A |
| Revenue | ★ $16,554,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $13.09 | $2.36 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.84 | ★ N/A |
| Revenue Growth | ★ 13.94 | 3.70 |
| 52 Week Low | $25.89 | $81.20 |
| 52 Week High | $38.88 | $129.27 |
Technical Indicators
Market Signals| Indicator | DVN | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 36.42 |
| Support Level | $37.07 | $94.52 |
| Resistance Level | $38.29 | $97.35 |
| Average True Range (ATR) | 0.87 | 2.51 |
| MACD | -0.13 | -0.26 |
| Stochastic Oscillator | 26.47 | 3.07 |
Price Performance
Historical ComparisonAbout DVN Devon Energy Corporation
Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. At the end of 2024, Devon reported net proved reserves of 2.2 billion barrels of oil equivalent. Net production averaged roughly 848,000 barrels of oil equivalent per day in 2024 at a ratio of 73% oil and natural gas liquids and 27% natural gas.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.